Tuesday - December 24, 2024
NYU Langone Health: Hair Growth Drug Safe at Low Doses for Breast Cancer Patients
December 10, 2024
NEW YORK, Dec. 10 (TNSres) -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:

The hair loss that can occur from chemotherapy sometimes causes enough distress for some women to lose self-confidence, which experts say may discourage them from seeking chemotherapy in the first place.

Oral minoxidil is a commonly prescribed treatment for hair loss. The drug is also the active ingredient in the over-the-c . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products